Oura, the smart ring maker, postponed its initial public offering on September 29, one week after launching it, citing uncertainty in the IPO market despite strong demand. The offering would have raised up to $2.2 billion, and the company chose to wait rather than accept a price at the low end of its range. For any owner thinking about a sale, a listing, or an outside investor, the episode shows what it costs to need a transaction on a particular date, and what it is worth to be able to decline one.
Oura set terms for an offering of 50 million shares at $40 to $44 each, which would have raised up to $2.2 billion. Existing shareholders were selling 36.5 million of those shares, so most of the proceeds would have gone to current holders rather than into the company. A week after launching, Oura announced the postponement, saying it was acting on uncertainty in the IPO market despite strong demand. According to Semafor, a person familiar with the matter said the shares looked set to price at the low end of the range. Oura says it is profitable, has 5.7 million paid members, and expects 2026 revenue to grow 90%. Chief executive Tom Hale said the company has the freedom to choose its timing, and he gave no new date.
Oura was not alone. Four companies seeking at least $50 million postponed or pulled offerings in the same week, and Holtec Nuclear withdrew its IPO the week before. Renaissance Capital counts seven such postponements or withdrawals in the third quarter, up from four in the second.
Renaissance Capital pointed to three pressures: concerns about AI spending, bond yields at a 19-year high, and the resumption of interest rate increases. Higher yields matter to a new issue because investors can earn more from safer assets, so they require a lower price, or a higher expected return, before buying shares of a newly listed company. Reuters tied Oura's delay to the same surge in yields. Analyst Gil Luria of DA Davidson added that investors have lost money on narrow consumer products, naming Peloton, GoPro, and Fitbit, which suggests the market weighed Oura's category as well as the calendar.
The quarter's totals show the same split. U.S. issuers completed 30 listings and raised $32.8 billion, but $26.5 billion came from one offering, SK hynix. Without it, proceeds were $6.2 billion.
The notable feature of Oura's decision is that it could make it. A profitable company that does not need the proceeds to fund operations can decline a price it considers too low. In finance this is called optionality: the ability to choose among alternatives, including doing nothing, without being forced by a deadline. It has real value, and in negotiations it shows up as leverage. A seller who must close by a certain date, because of a lender covenant, a partner's retirement, or a tax planning deadline, will generally accept worse terms than a seller who can wait another quarter.
Valuation work reflects this too. A price reached under pressure and a price reached by a patient seller are different data points, even for the same business. Buyers know it, and they probe for urgency in management meetings, in the diligence timeline, and in how quickly a seller responds to a revised offer.

Few owners are preparing a public offering, but the same dynamics apply to a private sale. Private company markets also move with interest rates and buyer confidence, and an owner who prepared early can choose when to transact. Preparation tends to involve three things.
First, financial records a buyer can trust. A quality of earnings analysis, which tests reported profit to separate recurring earnings from one-time items, shortens diligence and reduces the chance of a late price reduction. Second, a realistic view of your minimum acceptable terms before negotiations begin, including how much deferred or contingent consideration you will accept. Third, alternatives: more than one credible type of buyer, such as a strategic acquirer, a private equity sponsor, or a management or employee buyout, so that no single bidder knows you have nowhere else to go.
Some owners run a dual-track process, pursuing a sale and an outside financing or recapitalization in parallel, so that the outcome of one sets the floor for the other. It takes more effort and more disclosure, but it creates the freedom Oura's chief executive described.
Postponement is not free. Preparing a transaction costs money in legal, accounting, and banking fees, and it absorbs management time. A company that launched publicly has also shown the market its numbers and its pricing ambition, which can anchor later discussions. Conditions can worsen as well as improve, and an owner who waits for a better market may find that rates rise further. A long, uncertain process can also distract employees, customers, and suppliers.
The decision to wait should rest on a view of what you would accept and why, not on a hope that the market recovers. Oura's profitable, fast-growing position is what makes its patience credible. Owners with weaker results or heavier debt may find that the price available today is better than the one available later.
Three developments will clarify the picture. The first is whether Oura and the other postponed issuers return to the market, and at what price relative to the ranges they set. The second is the direction of long-term Treasury yields, which set the bar for new issues and private deals alike. The third is whether more postponements push companies toward private sales, sponsor-to-sponsor transactions, or private funding rounds, which would add supply to the markets where many owners sell.
Oura's postponement shows the value of being able to say no. A company with strong profits and no need for the proceeds chose to wait instead of selling at the low end of its range. Owners can build the same position by preparing their financial records early, knowing their minimum terms, and developing more than one path to a transaction. The cost of waiting is real, so the choice should rest on a clear number rather than optimism.